Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).

Women have a consistently higher prevalence of major depressive disorder (MDD) than men. Hypotheses implicating hypothalamic-pituitary -adrenal, -gonadal, and -thyroid axes, immune response, genetic factors, and neurotransmitters have emerged to explain this difference. However, more evidence for th...

Full description

Bibliographic Details
Main Authors: Jordan M Ramsey, Jason D Cooper, Mariska Bot, Paul C Guest, Femke Lamers, Cynthia S Weickert, Brenda W J H Penninx, Sabine Bahn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4883748?pdf=render
_version_ 1811211116412403712
author Jordan M Ramsey
Jason D Cooper
Mariska Bot
Paul C Guest
Femke Lamers
Cynthia S Weickert
Brenda W J H Penninx
Sabine Bahn
author_facet Jordan M Ramsey
Jason D Cooper
Mariska Bot
Paul C Guest
Femke Lamers
Cynthia S Weickert
Brenda W J H Penninx
Sabine Bahn
author_sort Jordan M Ramsey
collection DOAJ
description Women have a consistently higher prevalence of major depressive disorder (MDD) than men. Hypotheses implicating hypothalamic-pituitary -adrenal, -gonadal, and -thyroid axes, immune response, genetic factors, and neurotransmitters have emerged to explain this difference. However, more evidence for these hypotheses is needed and new explanations must be explored. Here, we investigated sex differences in MDD markers using multiplex immunoassay measurements of 171 serum molecules in individuals enrolled in the Netherlands Study of Depression and Anxiety (NMDD = 231; Ncontrol = 365). We found 28 sex-dependent markers of MDD, as quantified by a significant interaction between sex and log2-transformed analyte concentration in a logistic regression with diagnosis (MDD/control) as the outcome variable (p<0.05; q<0.30). Among these were a number of male-specific associations between MDD and elevated levels of proteins involved in immune response, including C-reactive protein, trefoil factor 3, cystatin-C, fetuin-A, β2-microglobulin, CD5L, FASLG receptor, and tumor necrosis factor receptor 2. Furthermore, only male MDD could be classified with an accuracy greater than chance using the measured serum analytes (area under the ROC curve = 0.63). These findings may have consequences for the generalization of inflammatory hypotheses of depression to males and females and have important implications for the development of diagnostic biomarker tests for MDD. More studies are needed to validate these results, investigate a broader range of biological pathways, and integrate this data with brain imaging, genetic, and other relevant data.
first_indexed 2024-04-12T05:07:14Z
format Article
id doaj.art-ae5e556ddf304526910864fdc5e44bc9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T05:07:14Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ae5e556ddf304526910864fdc5e44bc92022-12-22T03:46:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015662410.1371/journal.pone.0156624Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).Jordan M RamseyJason D CooperMariska BotPaul C GuestFemke LamersCynthia S WeickertBrenda W J H PenninxSabine BahnWomen have a consistently higher prevalence of major depressive disorder (MDD) than men. Hypotheses implicating hypothalamic-pituitary -adrenal, -gonadal, and -thyroid axes, immune response, genetic factors, and neurotransmitters have emerged to explain this difference. However, more evidence for these hypotheses is needed and new explanations must be explored. Here, we investigated sex differences in MDD markers using multiplex immunoassay measurements of 171 serum molecules in individuals enrolled in the Netherlands Study of Depression and Anxiety (NMDD = 231; Ncontrol = 365). We found 28 sex-dependent markers of MDD, as quantified by a significant interaction between sex and log2-transformed analyte concentration in a logistic regression with diagnosis (MDD/control) as the outcome variable (p<0.05; q<0.30). Among these were a number of male-specific associations between MDD and elevated levels of proteins involved in immune response, including C-reactive protein, trefoil factor 3, cystatin-C, fetuin-A, β2-microglobulin, CD5L, FASLG receptor, and tumor necrosis factor receptor 2. Furthermore, only male MDD could be classified with an accuracy greater than chance using the measured serum analytes (area under the ROC curve = 0.63). These findings may have consequences for the generalization of inflammatory hypotheses of depression to males and females and have important implications for the development of diagnostic biomarker tests for MDD. More studies are needed to validate these results, investigate a broader range of biological pathways, and integrate this data with brain imaging, genetic, and other relevant data.http://europepmc.org/articles/PMC4883748?pdf=render
spellingShingle Jordan M Ramsey
Jason D Cooper
Mariska Bot
Paul C Guest
Femke Lamers
Cynthia S Weickert
Brenda W J H Penninx
Sabine Bahn
Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
PLoS ONE
title Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
title_full Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
title_fullStr Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
title_full_unstemmed Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
title_short Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA).
title_sort sex differences in serum markers of major depressive disorder in the netherlands study of depression and anxiety nesda
url http://europepmc.org/articles/PMC4883748?pdf=render
work_keys_str_mv AT jordanmramsey sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT jasondcooper sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT mariskabot sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT paulcguest sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT femkelamers sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT cynthiasweickert sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT brendawjhpenninx sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda
AT sabinebahn sexdifferencesinserummarkersofmajordepressivedisorderinthenetherlandsstudyofdepressionandanxietynesda